1961
DOI: 10.1021/jo01067a008
|View full text |Cite
|
Sign up to set email alerts
|

Steroidal Aldosterone Antagonists. IV1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

1970
1970
2018
2018

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(6 citation statements)
references
References 2 publications
0
6
0
Order By: Relevance
“…Solutions of 19-substituted ADs (7, 0.18 mmol), chloranil (66 mg, 0.26 mmol), and p-toluenesulfonic acid (p-TsOH; 1.5 mg, 8 mol) in dry xylene (5 ml) were separately heated under reflux for 5 h under N 2 atmosphere [43]. After this time, the reaction mixture were subjected to a column of silica gel (12 g).…”
Section: Synthesis Of 19-substituted 6-ene-ads (9)mentioning
confidence: 99%
“…Solutions of 19-substituted ADs (7, 0.18 mmol), chloranil (66 mg, 0.26 mmol), and p-toluenesulfonic acid (p-TsOH; 1.5 mg, 8 mol) in dry xylene (5 ml) were separately heated under reflux for 5 h under N 2 atmosphere [43]. After this time, the reaction mixture were subjected to a column of silica gel (12 g).…”
Section: Synthesis Of 19-substituted 6-ene-ads (9)mentioning
confidence: 99%
“…With this goal 7α,9,11‐ene spirolactone derivatives 7 a–f were prepared from known triene 6 (Δ9,11‐canrenone) as outlined in Scheme . Reaction of 6 with the appropriate Grignard reagent gave the required 7α‐methyl and 7α‐ n ‐propyl derivatives 7 a, b following purification . 7α‐Thioethers 7 c–e were prepared by treatment of 6 with the corresponding sodium thiolate prepared in situ .…”
Section: Resultsmentioning
confidence: 99%
“…Most active was 3-(3,1l-dioxo-9a-fl.uoro-17p-hydroxy-4-androsten-17a-yl) propanoic acid lactone, which had about 5 times the subcutaneous and 100 times the oral blocking potency against desoxycorticosterone action in adrenalectomized rats as the basic structure, 3-(3-oxo-17p-hydroxy-4-androsten-17a-yl) propanoic acid lactone. Alterations of the above-mentioned 9a-fl.uoro lactone by addition of other substituents, including the 6a-fl.uoro group (BROWN and BURTNER, 1963) or 2a-methyl group (ATWATER et al, 1961) resulted in reduced mineralocorticoid-blocking activity.…”
Section: In Side Chainmentioning
confidence: 99%